Science
Intellectual Property
Introduction
Strong IP Position with many priority patent applications covering the BiXAb platform and its products.
New products and inventions on the BiXAb technology are covered by additional IP, providing further protection to BIOMUNEX inventions.
Many patent applications filed on the BiXAb platform technologies, including several patent families detained at 100% by Biomunex, that have been granted in most countries.
Several patent applications for each BiXAb lead product that has been developed; the objective is to worldwide protect all BIOMUNEX’ proprietary antibodies, that are in development.
Every year, BIOMUNEX is actively developing new intellectual property based on its own R&D efforts and in collaboration with academic teams and industrial partners.
Each year, several patent applications are filed on innovative biological approaches with the permanent objective to provide pharmaceutical partners not only high quality, but also highly protected bispecific and multi-specific antibodies for out-licensing and partnership deals.